Chronic Kidney Disease News

Depression is one of the most common complications of chronic illness. Depressive symptoms can have a negative effect on a person’s overall health and quality of life, while the hardships of a chronic illness can take a toll on mental health, creating a vicious cycle of deteriorating behavioral and physical health.

In March 2020, a group of nephrology pharmacists met to discuss ways to help improve patient lives and keep the nephrologist at the center of the patient care team.

Managing patients with an illness like chronic kidney disease can be difficult at times for caregivers, but Michelle Rowlett, MSW, LICSW, knows that for patients grappling with a disease that can last a lifetime, it poses many challenges.

Sobi and Apellis Pharmaceuticals Inc. announced results from the phase 3 Valiant study showing the drug pegcetacoplan reduced proteinuria and stabilized eGFR compared to placebo in patients with glomerulopathy or glomerulonephritis.

Higher intake of total, animal and plant protein may be linked to lower mortality in older adults with mild or moderate chronic kidney disease, according to a cohort study.

The FDA has granted accelerated approval for Fabhalta to treat proteinuria in patients with primary IgA nephropathy, according to a press release.

Meta Pharmaceuticals has received FDA rare pediatric disease designation for its investigational new drug META-001-PH, according to a press release.

Many dialysis care providers in the United States may have limited knowledge about dementia, according to a web-based survey.

Higher nutritional risk may be associated with infection-related hospitalization but not cardiovascular disease-related hospitalization in patients on dialysis, according to results of a prospective study.

Diality has received FDA 510(k) clearance for its Moda-flx Hemodialysis System for acute and/or chronic renal failure, according to a press release.